Journals / Bursa Devlet Hastanesi Bülteni / 2004 / Cilt: 19 - Sayı: 2

A case report of intracranial germ cell tumor

İntrakraniyal yerleşimli germ hücreli tümör olgusu

Pages
99–103
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New treatment protocols are needed to reduce the theropeutic side effects and mortality rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although primary intracranial germ cell tumors are rare, they comprimize a great proportion of pineal tumors.
📊
Key Findings & Data:Prognosis of them is related to pathologic subtypes.
💡
Conclusion & Impact:New treatment protocols are needed to reduce the theropeutic side effects and mortality rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although primary intracranial germ cell tumors are rare, they comprimize a great proportion of pineal tumors. Prognosis of them is related to pathologic subtypes. Germinomas are more frequent and have a benign course compared to non-germinatous types. Germinomas are curable with radiotherapy and chemotherapy. Non-germinomas are greatly radiosensitive. They require adjuvant radiotherapy I chemotherapy. New treatment protocols are needed to reduce the theropeutic side effects and mortality rates.

Özet

Primer intrakraniyal germ hücreli tümörler nadir görülen maligniteler olmalarına rağmen, pineal kaynaklı tümörlerin büyük kısmını oluştururlar. Prognozlan ve tedaviye yanıtlan patolojik subtiplerine göre değişir. Germinomlar, germinom olmayan tiplere göre daha sık görülürler ve benign seyrederler. Bu grup tümörlerde radyoterapi ve kemoterapi ile tam şifa elde edilebilmektedir. Non-germinatöz tümörler ise kısmen radyosensitıftır. Bu hastalara adjuvan radyoterapi ve/veya kemoterapi gereklidir. Bu hastalarda yan etkileri ve mortalite oranlarım azaltmak amacıyla yeni tedavi seçeneklerine ihtiyaç vardır.

🔖

Cite This Article

KURT, E., MANAVOĞLU, O., EVRENSEL, T., YILMAZLAR, S., GÖNÜLLÜ, G., KANAT, Ö., DEMİRAY, M., YALÇIN, R., GÖZKAMAN, A., ADIM, Ş., ARSLAN, M. (2022). A case report of intracranial germ cell tumor. Bursa Devlet Hastanesi Bülteni, Cilt: 19 - Sayı: 2, 99–103. https://ajindex.com/articles/469441

References (10)

  1. Levin VA, Leibel SA, Gutin PH: Neoplasms of the central nervous system (Eds, Devita VT, Hellman S, Rosenberg SA). Cancer. Principles & Practice of Oncology. Sixth Edition. Lip-pi ncott Williams & Wilkins, Philadelphia. 2001, pp 2100-60
  2. Cho B, Wang K, Nam D, Kim D, Jung H, Kim H, Han D, Choi K: Pineal tumors: experience with 48 cases over 10 years. Child's Nervs Syst 14:53-8, 1998
  3. Hoffman HJ: Pineal region tumors. Prog Exp Tumor Res 30:281,1987
  4. Saitoh M, Tamaki N, Kokunai T, Matsumoto S: Clinico-biolog-ical behavior of germ-cell tumors. Child's Nerv Syst 7:246-50, 1991
  5. Choi J, Kim D, Chung S, Kim T: Treatment of germ cell tumors in the pineal region. Child's Nerv Syst 14:41-8, 1998
  6. Posner J: Diagnosis and treatment of metastases to the brain. Lin Bull 4:47-57, 1974
  7. Regis J, Bouillot P, Rouby-Volot F, Figarella-Branger D, Dufour H, Peragut J C: Pineal region tumors and the role of stereotactic biopsy: Review of the mortality, morbidity and diagnostic rates in 370 cases. Neurosurgery 39:907-14, 1996
  8. Loughesy T, Selch M, Liau L: Primary neoplasms of the nervous system brain (Ed. Haskell CM). Cancer Treatment. Fifth Edition. WB Saunders Company, Philadelphia. 2001, pp 1106-42
  9. Matsukado Y, Abe H, Tanaka R, Kobayashi T, Yamashita J, Nishimoto A, Ushio Y, Sato K, Matsutani M, Takakura K: Cisp-latin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors. Jpn J Cancer Clin 32:1387-93, 1986
  10. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T: Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86:446-55, 1997.